Company Filing History:
Years Active: 1996-1998
Title: Innovations in Photodynamic Therapy by Tiechao Li
Introduction
Tiechao Li is a prominent inventor based in Montreal, Canada. He has made significant contributions to the field of photodynamic therapy, particularly in the development of novel rhodamine derivatives for cancer treatment. With a total of 2 patents, his work focuses on enhancing the efficacy of cancer therapies through innovative chemical compounds.
Latest Patents
Tiechao Li's latest patents include groundbreaking inventions related to rhodamine derivatives designed for photodynamic therapy of cancer. These derivatives are engineered to enhance high quantum-yield production and singlet oxygen generation upon light irradiation. The compounds maintain a desirable differential retention of rhodamine between normal and cancer cells, which is crucial for effective treatment. Some representative derivatives include 2-(4,5-dibromo-6-amino-3-imino-3H-xanthen-9-yl)-benzoic acid methyl ester hydrochloride and 2-(6-ethyl amino-3-ethyl imino-3H-xanthen-9-yl)-benzoic acid n-butyl ester hydrochloride. These innovations aim to achieve appropriate intracellular levels of the derivatives, thereby inducing cell killing upon photoactivation.
Career Highlights
Tiechao Li is affiliated with the Université de Montreal, where he conducts research and develops his innovative ideas. His work has garnered attention in the scientific community for its potential to improve cancer treatment outcomes. His focus on photodynamic therapy represents a significant advancement in the fight against cancer.
Collaborations
Tiechao Li collaborates with esteemed colleagues such as Louis Gaboury and Luc Villeneuve. Their combined expertise contributes to the advancement of research in photodynamic therapy and the development of effective cancer treatments.
Conclusion
Tiechao Li's contributions to the field of photodynamic therapy through his innovative rhodamine derivatives highlight the importance of research in cancer treatment. His work not only showcases his inventiveness but also offers hope for improved therapeutic options for cancer patients.